Cargando…
Chemotherapy for anaplastic thyroid cancer using docetaxel and cisplatin: report of eight cases
Anaplastic thyroid carcinoma has a dismal prognosis and lacks an established therapeutic strategy. We have recently conducted chemotherapy with docetaxel and cisplatin as part of multimodal treatment for eight patients with anaplastic thyroid carcinoma. Docetaxel (75 mg/m²) and cisplatin (75 mg/m²)...
Autores principales: | Seto, Akira, Sugitani, Iwao, Toda, Kazuhisa, Kawabata, Kazuyoshi, Takahashi, Shunji, Saotome, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293457/ https://www.ncbi.nlm.nih.gov/pubmed/25734195 http://dx.doi.org/10.1007/s00595-013-0751-x |
Ejemplares similares
-
Sorafenib in Japanese Patients with Locally Advanced or Metastatic Medullary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma
por: Ito, Yasuhiro, et al.
Publicado: (2017) -
Concept and design of a nationwide prospective feasibility/efficacy/safety study of weekly paclitaxel for patients with pathologically confirmed anaplastic thyroid cancer (ATCCJ-PTX-P2)
por: Onoda, Naoyoshi, et al.
Publicado: (2015) -
Lenvatinib for Anaplastic Thyroid Cancer
por: Tahara, Makoto, et al.
Publicado: (2017) -
Surgery did not improve the subjective neuropsychological symptoms of patients with incidentally detected mild primary hyperparathyroidism
por: Tsukahara, Kiyoaki, et al.
Publicado: (2007) -
Complete Remission of Anaplastic Thyroid Carcinoma after Concomitant Treatment with Docetaxel and Radiotherapy
por: Abe, Ichiro, et al.
Publicado: (2015)